[HTML] frontiersin.org

[HTML][HTML] Efficacy and safety of abiraterone acetate and enzalutamide for the treatment of metastatic castration-resistant prostate cancer: a systematic review and meta …

ZH Wei, CX Chen, BW Li, YY Li, H Gu - Frontiers in oncology, 2021 - frontiersin.org
Objective The androgen receptor-targeting drugs abiraterone acetate and enzalutamide
have shown positive results as treatments for metastatic castration-resistant prostate cancer …
被引用次数：12 相关文章
[HTML] nih.gov

[HTML][HTML] Efficacy and Safety of Abiraterone Acetate and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and …

ZH Wei, CX Chen, BW Li, YY Li, H Gu - Frontiers in Oncology, 2021 - ncbi.nlm.nih.gov
Objective The androgen receptor-targeting drugs abiraterone acetate and enzalutamide
have shown positive results as treatments for metastatic castration-resistant prostate cancer …

Efficacy and Safety of Abiraterone Acetate and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta …

ZH Wei, CX Chen, BW Li, YY Li… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Objective The androgen receptor-targeting drugs abiraterone acetate and enzalutamide
have shown positive results as treatments for metastatic castration-resistant prostate cancer …

Efficacy and Safety of Abiraterone Acetate and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta …

Z Wei, C Chen, B Li, Y Li, H Gu - Frontiers in Oncology, 2021 - europepmc.org
Objective The androgen receptor-targeting drugs abiraterone acetate and enzalutamide
have shown positive results as treatments for metastatic castration-resistant prostate cancer …